Tomatidine-stimulated maturation of human embryonic stem cell-derived cardiomyocytes for modeling mitochondrial dysfunction

참고문헌 (57)

1. Ferri, N., "Drug attrition during pre-clinical and clinical development : understanding and managing drug-induced cardiotoxicity", Pharmacol. Ther, 138, pp.470~484 (2013)
2. Gintant, G., "Evolution of strategies to improve preclinical cardiac safety testing", Nat. Rev. Drug Discov, 15, pp.457~471 (2016)
3. Stella Stoter, A. M., "Assessment of cardiotoxicity with stem cell-based strategies", Clin. Ther, 42, pp.1892~1910 (2020)
4. Lian, X., "Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt", beta-catenin signaling under fully defined conditions, 2013, pp.8, 162~175
5. Zhu, W. Z., "Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes", PLoS ONE, 4, pp.e5407~ (2009)
6. Karbassi, E., "Cardiomyocyte maturation : advances in knowledge and implications for regenerative medicine", Nat. Rev. Cardiol, 17, pp.341~359 (2020)
7. Robertson, C., "Concise review : maturation phases of human pluripotent stem cell-derived cardiomyocytes", Stem Cells, 31, pp.829~837 (2013)
8. Varga, Z. V., "Drug-induced mitochondrial dysfunction and cardiotoxicity", Am. J. Physiol. Heart Circ. Physiol, 309, pp.H1453~H1467 (2015)
9. Ikon, N., "Cardiolipin and mitochondrial cristae organization", Biochim. Biophys. Acta Biomembr, 1859, pp.1156~1163 (2017)
10. Goormaghtigh, E., "Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity", Biophys. Chem, 35, pp.247~257 (1990)
11. Aryal, B., "Deficiency in cardiolipin reduces doxorubicin-induced oxidative stress and mitochondrial damage in human B-lymphocytes", PLoS ONE, 11, pp.e0158376~ (2016)
12. Wallace, K. B., "Mitochondrial determinants of doxorubicin-induced cardiomyopathy", Circ. Res, 126, pp.926~941 (2020)
13. Cui, N., "Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIalpha to IIbeta in human stem cell derived cardiomyocytes", J. Cell Mol. Med, 23, pp.4627~4639 (2019)
14. Waltz, T. B., "Sarcopenia, aging and prospective interventional strategies", Curr. Med. Chem, 25, pp.5588~5596 (2018)
15. Jiang, Q. W., "Therapeutic potential of steroidal alkaloids in cancer and other diseases", Med. Res. Rev, 36, pp.119~143 (2016)
16. Dyle, M. C., "Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy", J. Biol. Chem, 289, pp.14913~14924 (2014)
17. Ebert, S. M., "Identification and small molecule inhibition of an activating transcription factor 4 (ATF4)-dependent pathway to age-related skeletal muscle weakness and atrophy", J. Biol. Chem, 290, pp.25497~25511 (2015)
18. Rutkowski, D. T., "All roads lead to ATF4", Dev. Cell, 4, pp.442~444 (2003)
19. Fang, E. F., "Tomatidine enhances lifespan and healthspan in C. elegans through mitophagy induction via the SKN-1", Nrf2 pathway, 2017, pp.7, 46208~
20. Yang, X., "Engineering adolescence : maturation of human pluripotent stem cell-derived cardiomyocytes", Circ. Res, 114, pp.511~523 (2014)
21. Brette, F., "T-tubule function in mammalian cardiac myocytes", Circ. Res, 92, pp.1182~1192 (2003)
22. De La Mata, A., "BIN1 induces the formation of T-tubules and adult-like Ca(2+) release units in developing cardiomyocytes", Stem Cells, 37, pp.54~64 (2019)
23. Hong, T., "Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia", Nat. Med, 20, pp.624~632 (2014)
24. Takeshima, H., "Junctophilins : a novel family of junctional membrane complex proteins", Mol. Cell, 6, pp.11~22 (2000)
25. Folmes, C. D., "Mitochondria in control of cell fate", Circ. Res, 110, pp.526~529 (2012)
26. Chung, S., "Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells", Nat. Clin. Pract. Cardiovasc. Med, 4, pp.S60~S67 (2007)
27. Katz, A. M., "Regulation of cardiac contraction and relaxation", Circulation, 102, pp.IV69~IV74 (2000)
28. Li, G. R., "Pharmacology of cardiac potassium channels", Adv. Pharmacol, 59, pp.93~134 (2010)
29. Aas, T., "Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients", Nat. Med, 2, pp.811~814 (1996)
30. Kuerer, H. M., "Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicinbased neoadjuvant chemotherapy", J. Clin. Oncol, 17, pp.460~469 (1999)
31. Singal, P. K., "Doxorubicin-induced cardiomyopathy", N. Engl. J. Med, 339, pp.900~905 (1998)
32. Von Hoff, D. D., "Risk factors for doxorubicin-induced congestive heart failure", Ann. Intern. Med, 91, pp.710~717 (1979)
33. Zhang, S., "Identification of the molecular basis of doxorubicin-induced cardiotoxicity", Nat. Med, 18, pp.1639~1642 (2012)
34. Chatterjee, K., "Doxorubicin cardiomyopathy", Cardiology, 115, pp.155~162 (2010)
35. Tamai, T., "Rheb(Ras homologue enriched in brain)-dependent mammalian target of rapamycin complex 1(mTORC1)activation becomes indispensable for cardiac hypertrophic growth after early postnatal period", J. Biol. Chem, 288, pp.10176~10187 (2013)
36. Kunkel, S. D., "mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass", Cell Metab, 13, pp.627~638 (2011)
37. Chen, J., "Ursolic acid induces mitochondrial biogenesis through the activation of AMPK and PGC-1 in C2C12 myotubes : a possible mechanism underlying its beneficial effect on exercise endurance", Food Funct, 8, pp.2425~2436 (2017)
38. Hasan, A., "Age-dependent maturation of iPSC-CMs leads to the enhanced compartmentation of beta2AR-cAMP signalling", Cells, 9, pp.2275~ (2020)
39. Lee, Y. K., "Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway", Mol. Endocrinol, 24, pp.1728~1736 (2010)
40. Kuppusamy, K. T., "Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes", Proc. Natl Acad. Sci. USA, 112, pp.E2785~E2794 (2015)
41. Montessuit, C., "Effects of insulin-like growth factor-I on the maturation of metabolism in neonatal rat cardiomyocytes", Pflug. Arch, 452, pp.380~386 (2006)
42. Kim, C., "Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation", Stem Cells Dev, 19, pp.783~795 (2010)
43. Yoshida, S., "Maturation of human induced pluripotent stem cell-derived cardiomyocytes by soluble factors from human mesenchymal stem cells", Mol. Ther, 26, pp.2681~2695 (2018)
44. Yang, X., "Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells", Stem Cell Rep, 13, pp.657~668 (2019)
45. Snir, M., "Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes", Am. J. Physiol. Heart Circ. Physiol, 285, pp.H2355~H2363 (2003)
46. Huang, C. Y., "Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment", J. Mol. Cell Cardiol, 138, pp.1~11 (2020)
47. Ronaldson-Bouchard, K., "Advanced maturation of human cardiac tissue grown from pluripotent stem cells", Nature, 556, pp.239~243 (2018)
48. Liu, A., "Functional characterization of inward rectifier potassium ion channel in murine fetal ventricular cardiomyocytes", Cell Physiol. Biochem, 26, pp.413~420 (2010)
49. Dhamoon, A. S., "The inward rectifier current(IK1)controls cardiac excitability and is involved in arrhythmogenesis", Heart Rhythm, 2, pp.316~324 (2005)
50. Ge, F., "Engineered maturation approaches of human pluripotent stem cell-derived ventricular cardiomyocytes", Cells, 9, pp.9~ (2019)
51. Feric, N. T., "Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues", Adv. Drug Deliv. Rev, 96, pp.110~134 (2016)
52. Lesmana, R., "Thyroid hormone stimulation of autophagy is essential for mitochondrial biogenesis and activity in skeletal muscle", Endocrinology, 157, pp.23~38 (2016)
53. Dorn, G. W., "Mitochondrial biogenesis and dynamics in the developing and diseased heart", Genes Dev, 29, pp.1981~1991 (2015)
54. Cui, A., "Dexamethasone-induced Kruppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia", J. Clin. Invest, 129, pp.2266~2278 (2019)
55. Bocco, B. M., "Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in skeletal muscle", J. Physiol, 594, pp.5255~5269 (2016)
56. Schuler, M., "PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2diabetes", Cell Metab, 4, pp.407~414 (2006)
57. Maillet, A., "Modeling doxorubicin-induced cardiotoxicity in human pluripotent stem cell derived-cardiomyocytes", Sci. Rep, 6, pp.25333~ (2016)

관련 논문AI추천